Mar 13, 2025 / 12:30PM GMT
Fabrice Chouraqui - Pharming Group NV - Chief Executive Officer & Executive Director
Thank you very much. Hello, everyone, and welcome to the Farming Full year and Q4 2024 financial results call. I'm Fabrice Chouraqui, CEO of Pharming , and I'll be joined on this call today by Steven Toor, our Chief Commercial Officer; Anurag Relan, our Chief Medical Officer; and Jeroen Wakkerman, our Chief Financial Officer.
We will be making forward-looking statements in this call that are based upon our current insights and plans. As you know, this may differ from future results.
First of all, let me say that I'm really excited to be joining Pharming, and it's an honor to succeed Sijmen de Vries. I'm passionate about progressing medical sciences and bringing innovation to patients. And naturally, I feel deeply connected with Pharming's mission to serve the unserved rare disease patients. Over the past 25 years, I've developed an experience across the business spectrum from pre-clinical research and clinical development to commercial leadership, business development, and capital formation.
Q4 2024 Pharming Group NV Earnings Call Transcript
Mar 13, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers